Commission buys COVID vaccine from Spain’s HIPRA

The European Commission has closed a deal for up to 250 million doses of the coronavirus vaccine developed by Spanish pharmaceutical company HIPRA, it announced Tuesday. The vaccine is still being assessed. The European Medicines Agency in March started a rolling review of the shot, which is designed to protect against both the Alpha and […]

Continue Reading